T1	Participants 45 74	head and neck cancer patients
T2	Participants 91 111	head and neck cancer
T3	Participants 678 733	patients undergoing treatment for head and neck cancers
T4	Participants 1280 1335	patients undergoing treatment for head and neck cancers
